We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+24.71%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
+$149M
(+21%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$4.71M |
| 2 |
GIMO
Gigamon Inc.
GIMO
|
+$4.45M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$4.39M |
| 4 |
SAAS
inContact, Inc.
SAAS
|
+$4.38M |
| 5 |
INN
Summit Hotel Properties
INN
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.11M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$5.46M |
| 3 |
RadNet
RDNT
|
+$5.41M |
| 4 |
PLNR
PLANAR SYSTEMS INC
PLNR
|
+$4.97M |
| 5 |
Motorcar Parts of America
MPAA
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.59% |
| 2 | Technology | 18.66% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Industrials | 11.89% |
| 5 | Communication Services | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Rogers Corp
ROG
$2.24B
| $3.27M | 0.38% |
39,752
+7,745
| +24% | +$609K |
|
127
Forward Air
FWRD
$464M
| $3.27M | 0.38% |
+60,128
| New | +$3.07M |
|
128
RingCentral
RNG
$4.81B
| $3.24M | 0.37% |
+211,367
| New | +$3.18M |
|
|
IPXL
129
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.24M | 0.37% |
69,111
-7,970
| -10% | -$317K |
|
|
IDTI
130
DELISTED
Integrated Device Technology I
IDTI
| $3.24M | 0.37% |
161,658
+31,454
| +24% | +$619K |
|
131
Advanced Energy
AEIS
$11.9B
| $3.23M | 0.37% |
+126,087
| New | +$3.21M |
|
132
ScottsMiracle-Gro
SMG
$3.97B
| $3.23M | 0.37% |
+48,052
| New | +$3.13M |
|
133
Ziff Davis
ZD
$1.99B
| $3.23M | 0.37% |
+56,521
| New | +$3.15M |
|
134
SPS Commerce
SPSC
$2.72B
| $3.22M | 0.37% |
+96,096
| New | +$3.06M |
|
135
Citi Trends
CTRN
$582M
| $3.21M | 0.37% |
118,959
-24,628
| -17% | -$622K |
|
136
Halozyme
HALO
$9.76B
| $3.2M | 0.37% |
+224,384
| New | +$3.24M |
|
|
VSLR
137
DELISTED
VIVINT SOLAR, INC.
VSLR
| $3.2M | 0.37% |
+263,564
| New | +$2.49M |
|
|
ZAGG
138
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $3.19M | 0.37% |
+368,424
| New | +$2.7M |
|
|
AGEN
139
Agenus
AGEN
$326M
| $3.19M | 0.37% |
+31,663
| New | +$3.16M |
|
|
HRC
140
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.16M | 0.36% |
+64,462
| New | +$3.07M |
|
141
Post Holdings
POST
$4.09B
| $3.12M | 0.36% |
+101,881
| New | +$3.11M |
|
|
VRNT
142
DELISTED
Verint Systems
VRNT
| $3.12M | 0.36% |
98,821
+19,190
| +24% | +$564K |
|
|
TNAV
143
DELISTED
Telenav Inc.
TNAV
| $3.11M | 0.36% |
393,035
+2,454
| +0.6% | +$18.9K |
|
|
BIG
144
DELISTED
Big Lots, Inc.
BIG
| $3.1M | 0.36% |
+64,588
| New | +$3.05M |
|
|
CPHD
145
DELISTED
Cepheid Inc
CPHD
| $3.1M | 0.36% |
54,491
-9,856
| -15% | -$554K |
|
146
AtriCure
ATRC
$1.97B
| $3.1M | 0.36% |
+151,186
| New | +$2.93M |
|
|
BSTC
147
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $3.09M | 0.36% |
78,901
+530
| +0.7% | +$20.8K |
|
|
PGNX
148
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $3.09M | 0.36% |
516,289
-37,020
| -7% | -$233K |
|
|
QLIK
149
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $3.04M | 0.35% |
97,657
+18,980
| +24% | +$581K |
|
150
Repligen
RGEN
$8.3B
| $3.03M | 0.35% |
99,914
-16,747
| -14% | -$434K |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
ICCFIA
PLFA
EAM Investors's Q1 2015 Portfolio in Review
As of Q1 2015, EAM Investors held 453 positions worth $866M, up 21% from $717M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
EAM Investors deployed $43.9M of net new capital in Q1 2015, opening 147 new positions and adding to 91 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Esperion Therapeutics, an estimated $6.11M trimmed.
- EAM Investors's largest Q1 2015 buy was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
- EAM Investors added most to NEVRO CORP. in Q1 2015, an estimated $3.15M increase.
- EAM Investors's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $6.11M.
- EAM Investors fully exited Imperva, Inc. in Q1 2015, selling an estimated $5.46M.
- EAM Investors's ten largest holdings make up 7.1% of its $866M portfolio in Q1 2015.
- EAM Investors opened 147 new positions and closed 130 in Q1 2015.
- EAM Investors's portfolio value rose 21% quarter-over-quarter to $866M.
Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.